ConserV Bio partners with eTheRNA on mRNA vaccine development
Collaboration will focus on vaccines for infectious diseases
Read More
Tag: ConserV Bioscience
ConserV Bioscience to develop ‘broad-spectrum’ coronavirus vaccine
UK biotech company will collaborate with Lawrence Livermore National Laboratory
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
